Canadian Recommendations for the Prevention and Treatment
of Malaria Among International Travellers
Supplement
June 2004 Volume
30S1
PDF
Version (142
KB)
Contained in this issue:
Table of Contents![Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers](/web/20061210175927im_/http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/04vol30/30s1/gfx/malaria.gif)
- Introduction
- Prevention
- Risk of Acquiring Malaria
- Personal Protective Measures to Prevent Mosquito Bites
- Chemoprophylactic Drugs (where appropriate)
- Early Diagnosis and Treatment
- Chemoprophylactic Regimens
- Introduction
- Chloroquine-sensitive Regions
- Chloroquine-resistant Regions
- Chloroquine- and Mefloquine-resistant Regions
- Primaquine Terminal Prophylaxis for Prevention of Relapses of
P. vivax and P. ovale
- Selection of Antimalarial Drugs for Individual Travellers
- Prevention of Malaria in Special Hosts
- Malaria Prevention in Children
- Malaria Prevention in Pregnancy
- Prophylaxis While Breast-Feeding
- Malaria Prevention in the Medically Compromised Host
- Malaria Prevention in the Long-term Traveller
or Expatriate
- Self-treatment of Presumptive Malaria
Step 1. Discuss Common Errors Concerning Malaria
Recognition and Management
Step 2. Advise that Malaria Presents in Various
ways
Step 3. Indicate the Need to Seek Professional
Medical Care As Soon As Possible
Step 4. Select the Self-treatment Drug with Care
Step 5. Educate About Drugs to Avoid
- Malaria Diagnosis
- Treatment of Malaria
- General Principles of Management
- Management of Falciparum Malaria
- Management of Non-falciparum Malaria
- Drugs for the Prevention and Treatment
of Malaria
Appendix I. Malaria Risk
by Geographic Area in Countries with Endemic Malaria
Appendix II. Strength
and Quality of Evidence Summary
Appendix III. Instructions
for Insecticide Treatment of Bed Nets and Clothing
Appendix IV. Checklist
for Travellers to Malarial Areas
Appendix V. Frequently
Asked Questions about Malaria
Appendix VI. Contact Information
for the Canadian Malaria Network
Preface
The prevention and treatment of malaria have changed considerably over
the last decade, primarily as a result of the development and spread of
drug-resistant parasites and a global resurgence of disease.
The following recommendations are guidelines prepared by the Malaria Subcommittee
of CATMAT for health care providers to assist travellers in preventing symptomatic
malaria and reducing the risk of severe illness or death from this infection.
The Travel Medicine Program at
Health Canada provides a valuable resource for the traveller and the
travel medicine provider. Information concerning malaria and many aspects
of the health of travelling Canadians is available at www.travelhealth.gc.ca.
CATMAT Members
Dr. B. Ward (Chairman); H. Birk; M. Bodie-Collins (Executive Secretary); Dr.
H.O. Davies; Dr. M-H Favreau; Dr. K. Gamble; Dr. S. Kuhn; Dr. A. McCarthy;
Dr. P.J. Plourde; Dr. J.R. Salzman
Liaison Representatives
Dr. R. Birnbaum (CSIH); L. Cobb (CUSO); Dr. V. Marchessault (CPS and NACI);
Dr. H. Onyette (CIDS); Dr. R. Saginur (CPHA)
Ex-Officio Representatives
Dr. E. Callary (HC); R. Dewart (CDC); Dr. E. Gadd (TPD); Dr. N. Gibson (DND);
Dr. M. Lapointe (CIC); Dr. V. Lentini (DND); Dr. M. Parise (CDC)
Member Emeritus
Dr. C.W.L. Jeanes
Malaria Subcommittee Members
Dr. A.E. McCarthy (Chair); Dr. K. Gamble; Dr. S. Kuhn; Dr. P.J. Plourde; Dr.
P. McDonald; Dr. M. Parise; Dr. N. Gibson; Dr. K. McLean; Dr. C. Greenaway;
Dr. M. Tepper
June 2004 Volume
30S1
PDF
Version (142
KB)
|